OBJECTIVE: Hypercholesterolemia is an early risk factor for Alzheimer's disease. Low-density lipoprotein (LDL) receptors might be involved in this disorder. Our objective was to determine the risk of mild cognitive impairment in a population of patients with heterozygous familial hypercholesterolemia, a condition involving LDL receptor dysfunction and lifelong hypercholesterolemia. METHODS: By using a cohort study design, patients with familial hypercholesterolemia (N=47) meeting inclusion criteria and comparison patients without familial hypercholesterolemia (N=70) were consecutively selected from academic specialty and primary care clinics, respectively. All patients were older than 50 years. Those with disorders that could affect cognition, including history of stroke or transient ischemic attacks, were excluded from both groups. Thirteen standardized neuropsychologic tests were performed in all subjects. Mutational analysis was performed in patients with familial hypercholesterolemia, and brain imaging was obtained in those with familial hypercholesterolemia and mild cognitive impairment. RESULTS: Patients with familial hypercholesterolemia showed a high incidence of mild cognitive impairment compared with those without familial hypercholesterolemia (21.3% vs 2.9%; P=.00). This diagnosis was unrelated to structural pathology or white matter disease. There were significant differences, independent of apolipoprotein E4 or E2 status, between those with familial hypercholesterolemia and those with no familial hypercholesterolemia in several cognitive measures, all in the direction of worse performance for those with familial hypercholesterolemia. CONCLUSION: Because prior studies have shown that older patients with sporadic hypercholesterolemia do not show a higher incidence of mild cognitive impairment, the findings presented suggest that early exposure to elevated cholesterol or LDL receptor dysfunction may be risk factors for mild cognitive impairment. 2010 Elsevier Inc. All rights reserved.
OBJECTIVE:Hypercholesterolemia is an early risk factor for Alzheimer's disease. Low-density lipoprotein (LDL) receptors might be involved in this disorder. Our objective was to determine the risk of mild cognitive impairment in a population of patients with heterozygous familial hypercholesterolemia, a condition involving LDL receptordysfunction and lifelong hypercholesterolemia. METHODS: By using a cohort study design, patients with familial hypercholesterolemia (N=47) meeting inclusion criteria and comparison patients without familial hypercholesterolemia (N=70) were consecutively selected from academic specialty and primary care clinics, respectively. All patients were older than 50 years. Those with disorders that could affect cognition, including history of stroke or transient ischemic attacks, were excluded from both groups. Thirteen standardized neuropsychologic tests were performed in all subjects. Mutational analysis was performed in patients with familial hypercholesterolemia, and brain imaging was obtained in those with familial hypercholesterolemia and mild cognitive impairment. RESULTS:Patients with familial hypercholesterolemia showed a high incidence of mild cognitive impairment compared with those without familial hypercholesterolemia (21.3% vs 2.9%; P=.00). This diagnosis was unrelated to structural pathology or white matter disease. There were significant differences, independent of apolipoprotein E4 or E2 status, between those with familial hypercholesterolemia and those with no familial hypercholesterolemia in several cognitive measures, all in the direction of worse performance for those with familial hypercholesterolemia. CONCLUSION: Because prior studies have shown that older patients with sporadic hypercholesterolemia do not show a higher incidence of mild cognitive impairment, the findings presented suggest that early exposure to elevated cholesterol or LDL receptordysfunction may be risk factors for mild cognitive impairment. 2010 Elsevier Inc. All rights reserved.
Authors: L M Refolo; M A Pappolla; J LaFrancois; B Malester; S D Schmidt; T Thomas-Bryant; G S Tint; R Wang; M Mercken; S S Petanceska; K E Duff Journal: Neurobiol Dis Date: 2001-10 Impact factor: 5.996
Authors: L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla Journal: Neurobiol Dis Date: 2000-08 Impact factor: 5.996
Authors: S Kalmijn; D Foley; L White; C M Burchfiel; J D Curb; H Petrovitch; G W Ross; R J Havlik; L J Launer Journal: Arterioscler Thromb Vasc Biol Date: 2000-10 Impact factor: 8.311
Authors: Miia Kivipelto; Eeva-Liisa Helkala; Mikko P Laakso; Tuomo Hänninen; Merja Hallikainen; Kari Alhainen; Susan Iivonen; Arto Mannermaa; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen Journal: Ann Intern Med Date: 2002-08-06 Impact factor: 25.391
Authors: Miguel A Pappolla; Mark A Smith; Tara Bryant-Thomas; Nicolas Bazan; Suzana Petanceska; George Perry; Leon J Thal; Mary Sano; Lorenzo M Refolo Journal: Free Radic Biol Med Date: 2002-07-15 Impact factor: 7.376
Authors: M A Pappolla; T K Bryant-Thomas; D Herbert; J Pacheco; M Fabra Garcia; M Manjon; X Girones; T L Henry; E Matsubara; D Zambon; B Wolozin; M Sano; F F Cruz-Sanchez; L J Thal; S S Petanceska; L M Refolo Journal: Neurology Date: 2003-07-22 Impact factor: 9.910
Authors: Z Arvanitakis; J A Schneider; R S Wilson; J L Bienias; J F Kelly; D A Evans; D A Bennett Journal: Neurology Date: 2008-01-16 Impact factor: 9.910
Authors: Carlos Ramírez; Saleta Sierra; Inmaculada Tercero; Jose Antonio Vázquez; Antonia Pineda; Tatiana Manrique; Javier S Burgos Journal: PLoS One Date: 2011-07-26 Impact factor: 3.240
Authors: Tim Vanmierlo; Kris Rutten; Leonie C van Vark-van der Zee; Silvia Friedrichs; Vincent W Bloks; Arjan Blokland; Frans C Ramaekers; Eric Sijbrands; Harry Steinbusch; Jos Prickaerts; Folkert Kuipers; Dieter Lütjohann; Monique Mulder Journal: Plant Foods Hum Nutr Date: 2011-06 Impact factor: 3.921
Authors: Bernard G Schreurs; Desheng Wang; Carrie A Smith-Bell; Lauren B Burhans; Roger Bell; Jimena Gonzalez-Joekes Journal: Int J Alzheimers Dis Date: 2012-04-11